Written question asked by Peter Dowd (Labour) on Monday, 11 December 2023, in the House of Commons. It was due for an answer on Wednesday, 13 December 2023. It was answered by Andrew Stephenson (Conservative) on Tuesday, 19 December 2023 on behalf of the Department of Health and Social Care.
Dermatitis: Medical Treatments
- Question
-
To ask the Secretary of State for Health and Social Care, if she will have discussions with NICE on developing (a) national guidelines and (b) quality standards for the management of severe eczema in adults.
- Answer
-
The Department regularly holds discussions with colleagues in the National Institute for Health and Care Excellence (NICE) about its guidelines programme. NICE has reviewed its guideline portfolio to identify topics that it thinks will add the most value to the health and care system, considering key factors such as clinical benefit, cost effectiveness, the potential to increase productivity and support workforce issues and the potential to address health inequalities.
Atopic dermatitis (eczema) in young people and adults is one of the topics on which NICE will stop work for the time being to allow them to focus on key priorities. Topics that have been stopped will be reconsidered by NICE’s prioritisation board which is being established in Spring 2024 by its chief medical officer.
Secondary information
- Type
- Written question
- Reference
- 6281
- Session
- 2023-24
- Subjects
- Medical treatments Standards Dermatitis
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-19 17:36:45 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2023-24/6281
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2023-24/6281
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2023-24/6281